Glycemic variability: Measurement and utility in clinical medicine and research-one viewpoint

Diabetes Technology and Therapeutics

Volumn 13, Issue 11, 2011, Pages 1077-1080

  Rodbard, David ^a  

^a Biomedical Informatics Consultants LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ANALYTICAL PARAMETERS; BLOOD GLUCOSE MONITORING; CLINICAL RESEARCH; DIABETES MELLITUS; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HIGH BLOOD GLUCOSE INDEX; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LOW BLOOD GLUCOSE INDEX; MATHEMATICAL ANALYSIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; REFERENCE VALUES;

EID: 80055050523     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0104     Document Type: Review

References (43)

1. Cameron FJ, Baghurst PA, Rodbard D: Assessing glycaemic variation: why, how and when? Pediatr Endocrinol Rev 2010; 7(Suppl 3):432-444.
2. Rodbard D: Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol 2007;1:62-71.
3. Rodbard D: Predicting the risk of hypo-and hyperglycemia by time of day, date, and day of the week-new methods for calculation and graphical display [abstract 491-P]. Diabetes 2010;59(Suppl 1):A132.
4. Kilpatrick ES: Arguments for and against the role of glucose variability in the development of diabetes complications. J Diabetes Sci Technol 2009;3:649-655.
5. Weber C, Schnell O: The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther 2009;11:623-633.
6. Hirsch IB: Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther 2005;7:780-783. (Pubitemid 41572082)
7. Hirsch IB, Brownlee M: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2007;30:186-187. (Pubitemid 46052530)
8. Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006;295:1707-1708.
9. Schisano B, Tripathi G, McGee K, McTernan PG, Ceriello A: Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia 2011;54:1219-1226.
10. Siegelaar SE, Holleman F, Hoekstra JB, Devries JH: Glucose variability; does it matter? Endocr Rev 2010;31:171-182.
11. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH: Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009;52: 2229-2232.
12. Siegelaar SE, Kulik W, van Lenthe H, Mukherjee R, Hoekstra JB, Devries JH: A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obes Metab 2009;11:709-714.
13. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
14. Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32:1901-1903.
15. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P: Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008;34:612-616.
16. Snell-Bergeon JK, Rodbard D, Roman R, Garg S, Maahs D, Schauer I, Bergman B, Kinney GL, Rewers M: Glycaemic variability and coronary artery calcium: the Coronary Artery Calcification in Type 1 Diabetes Study. Diabet Med 2010; 27:1436-1442.
17. Siegelaar SE, Kerr L, Jacober SJ, Devries JH: A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabetes Care 2011;34:855-857.
18. Monnier L, Colette C: Glycemic variability: can we bridge the divide between controversies? Diabetes Care 2011;34: 1058-1059.
19. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group: HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 2011;54:69-72.
20. Standl E, Schnell O, Ceriello A: Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 2011;34(Suppl 2):S120-S127.
21. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes (ADRR). Diabetes Care 2006;29:2433-2438. (Pubitemid 44912248)
22. Mazze RS, Lucido D, Langer O, Hartmann K, Rodbard D: Ambulatory glucose profile: representation of verified selfmonitored blood glucose data. Diabetes Care 1987;10:111-117. (Pubitemid 17069078)
23. Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R: Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 2008;10:149-159. (Pubitemid 351677595)
24. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875. (Pubitemid 28478285)
25. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009;11 (Suppl 1):S45-S54.
26. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S55-S57.
27. Rodbard D: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009;11:551-565.
28. Rodbard D: Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med 2011; 123:107-118.
29. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758. (Pubitemid 47012121)
30. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg S: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11:717-723.
31. Rodbard D, Jovanovic L, Garg S: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther 2009;11:757-765.
32. Rodbard D: A semilogarithmic scale for glucose provides a balanced view of hyperglycemia and hypoglycemia. J Diabetes Sci Technol 2009;3:1395-1401.
33. Zisser HC, Biersmith MA, Jovanovïc LB, Yogev Y, Hod M, Kovatchev BP: Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol 2010; 4:1368-1373.
34. Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W: Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit 2011;17: CR9-CR13.
35. Baghurst PA: Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther 2011;13:296-302.
36. Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E: The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 2011;13:319-325.
37. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W: GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol 2011;5:447-451.
38. Wójcicki JM: "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
39. Monnier L, Wojtusciszyn A, Colette C, Owens D: The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther 2011;13:813-818.
40. Qu Y, Jacober S, Zhang Q, Wolka L, DeVries JH: The effect of glucose variability on the rate of hypoglycemic events. Abstract 478-P. Diabetes 2011; 60(Suppl 1):A133.
41. Dalfrà MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, Sposato J, Valgimigli F, Scuffi C, Scalese M, Lapolla A: Glucose variability in diabetic pregnancy. Diabetes Technol Ther 2011;13:853-859.
42. Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR: Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011;13:921-928.
43. Marling CR, Shubrook JH, Vernier SJ, Wiley MT, Schwartz FL: Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol 2011;5:871-878.